Xilio Therapeutics, Inc. Business Finance Contracts & Agreements
12 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Loan Agreements (3)
- Purchase Agreements (1)
- Registration Rights Agreements (2)
- Stock Agreements (3)
- Underwriting Agreements (1)
- Warrant Agreements (1)
- Investor Rights Agreement, dated March 27, 2024, between the Registrant and Gilead Sciences, Inc (Filed With SEC on May 14, 2024)
- Common Stock Purchase Agreement, dated March 27, 2024, between the Registrant and Gilead Sciences, Inc (Filed With SEC on May 14, 2024)
- Registration Rights Agreement, dated March 28, 2024, among Xilio Therapeutics, Inc. and the persons party thereto (Filed With SEC on March 28, 2024)
- Securities Purchase Agreement, dated March 28, 2024, among Xilio Therapeutics, Inc. and the persons party thereto (Filed With SEC on March 28, 2024)
- Form of Prefunded Warrant (Filed With SEC on March 28, 2024)
- Amended and Restated Loan and Security Agreement, dated as of May 5, 2023, by and between Xilio Development, Inc. and Pacific Western Bank (Filed With SEC on May 9, 2023)
- Loan and Security Agreement, dated as of November 21, 2019, as amended, by and between the Registrant and Pacific Western Bank (Filed With SEC on May 12, 2022)
- 2021 Employee Stock Purchase Plan (Filed With SEC on October 18, 2021)
- Form of Underwriting Agreement (Filed With SEC on October 18, 2021)
- Loan and Security Agreement, dated as of November 21, 2019, as amended, by and between the Registrant and Pacific Western Bank (Filed With SEC on October 1, 2021)
- Amended and Restated Registration Rights Agreement, dated as of February 23, 2021, by and among the Registrant and the other parties thereto (Filed With SEC on October 1, 2021)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on October 1, 2021)
